• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC. THERMOCOOL SMART TOUCH ELECTROPHYSIOLOGY CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC. THERMOCOOL SMART TOUCH ELECTROPHYSIOLOGY CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number D133602
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Edema (2020); Blood Loss (2597)
Event Date 10/06/2020
Event Type  Injury  
Manufacturer Narrative
The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 30326569m number, and no internal action related to the reported complaint was found during the review.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event Description
During a clinical trial, sponsored by bwi, it was reported that a (b)(6) year-old female patient (82.4 kg, 66 in) underwent a cardiac ablation procedure on (b)(6) 2020 with a thermocool® smart touch¿ electrophysiology catheter and post procedure developed pulmonary edema and bleeding.A total of 110 radiofrequency applications were delivered with the thermocool® smart touch¿ electrophysiology catheter.No device deficiencies were reported.The procedure was successfully completed without patient consequences.Post-procedure, on (b)(6) 2020, the patient developed leakage of blood into lungs (pulmonary edema) and left atrial septal mass hematoma (less likely thrombus).No medical/surgical intervention nor extended hospitalization was required (patient was discharged the same day).Issue is resolving.The principal investigator assessed the event as expected, mild in severity, not serious, not related to the study device (visitag surpoint epu), probable related to the study catheter, not related to the bwi non-investigational devices (e.G.Pump, tubing, cables, etc) and probable related to the index procedure.Due to the implied relationship to the study catheter and procedure, this event is being coded as ¿pulmonary edema¿ and ¿bleeding¿.Bleeding code is being selected to represent the left atrial septal mass hematoma reported for this clinical study.Source documentation will be requested to obtain further details/clarification regarding this event.Should more information become available, it will be reviewed and processed accordingly.
 
Manufacturer Narrative
On 11/18/2020, biosense webster inc.Received additional information indicating the adverse event term has been updated from ¿leakage of blood into lungs or other organs due to perforation¿ to ¿left atrial septal mass hematoma vs.Less likely thrombus¿ on 11/25/2020, additional information was received indicating there was no leakage of blood into the lungs, as such, this event will no longer be considered to be a pulmonary edema and no longer considered to be an mdr reportable event.The reported left atrial septal mass hematoma is considered to be a non-serious patient event since there were no interventions and no extended hospitalization was required to treat the septal mass hematoma.Source documentation indicates ¿there were no intraprocedural complications¿.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# pc-(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL SMART TOUCH ELECTROPHYSIOLOGY CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC.
33 technology drive
irvine CA 92618
MDR Report Key10797357
MDR Text Key215074466
Report Number2029046-2020-01641
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835009002
UDI-Public10846835009002
Combination Product (y/n)N
PMA/PMN Number
P030031/S053
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,study
Type of Report Initial,Followup
Report Date 10/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/09/2021
Device Model NumberD133602
Device Catalogue NumberD133602
Device Lot Number30326569M
Was Device Available for Evaluation? No
Date Manufacturer Received11/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CARTO 3 SYSTEM; CARTO3 EXTERNAL REFPATCH 6PACK; CBL, 34 HYP/34 LEMO, 10'; SMARTABLATE GENERATOR KIT-US; SMARTABLATE PUMP KIT-US; VISITAG SURPOINT EPU; CARTO 3 SYSTEM; CARTO3 EXTERNAL REFPATCH 6PACK; CBL, 34 HYP/34 LEMO, 10'; SMARTABLATE GENERATOR KIT-US; SMARTABLATE PUMP KIT-US; VISITAG SURPOINT EPU
Patient Outcome(s) Other;
Patient Age64 YR
Patient Weight82
-
-